Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Amlodipine and Candesartan in Healthy Male Volunteers
NCT02064556Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- May 2014
- Primary completion
- Jul 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypertension (HTN) comparing Amlodipine Monotherapy with Amlodipine + Candesartan (2 arms). Primary endpoints: Area Under the Concentration-time Curve at Steady State and Maximum Plasma Concentration at Steady State. Started May 2014; status: completed.
02
Drugs
amlodipinecandesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02064556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064556.